Balance Sheet Dollarama Inc.

Equities

DOL

CA25675T1075

Discount Stores

Real-time Estimate TE Other stock markets 22:33:30 21/05/2026 HKT			5-day change	1st Jan Change
175.83 ^CAD	+0.32%		+1.20%	-14.73%

05-12	Canada research roundup-Altius Minerals, Cipher Pharmaceuticals, Suncor Energy	RE
05-07	MÉDAC Submits Shareholder Proposals to Dollarama	CI

6af4e9158fe5136b303ee31e83.2ZFRFeWcrozeF6su5f-yDPWsXlZgN-wQRXzOLIE4Z0k.ssJoV7___NyxXNpckZnhVZbNJxolfdx6dBL5S-NgAiGMxTZ9nNjg6K5v6g

Published financial data: DOLLARAMA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: February	2022	2023	2024	2025	2026
Revenues	4.33B	5.05B	5.87B	6.41B	7.26B
Total Revenues	4.33B	5.05B	5.87B	6.41B	7.26B
Cost of Goods Sold, Total	2.28B	2.7B	3.08B	3.52B	3.99B
Gross Profit	2.05B	2.35B	2.78B	2.89B	3.27B
Selling General & Admin Expenses, Total	764M	871M	1.01B	930M	1.09B
Depreciation & Amortization - (IS)	298M	332M	348M	383M	429M
Other Operating Expenses, Total	1.06B	1.2B	1.36B	1.31B	1.52B
Operating Income	987M	1.15B	1.42B	1.58B	1.75B
Interest Expense, Total	-91.22M	-115M	-172M	-187M	-204M
Interest And Investment Income	-	-	27.25M	28.47M	25.67M
Net Interest Expenses	-91.22M	-115M	-145M	-159M	-178M
Income (Loss) On Equity Invest.	33.18M	45.4M	75.29M	130M	192M
Other Non Operating Income (Expenses)	-	-	-	-4.8M	-5.57M
EBT, Excl. Unusual Items	929M	1.08B	1.35B	1.55B	1.75B
Gain (Loss) On Sale Of Investments	-	-	-	-	10.35M
Other Unusual Items	-35.5M	-1.59M	-	-	-
EBT, Incl. Unusual Items	893M	1.08B	1.35B	1.55B	1.76B
Income Tax Expense	230M	274M	340M	378M	455M
Earnings From Continuing Operations	663M	802M	1.01B	1.17B	1.31B
Net Income to Company	663M	802M	1.01B	1.17B	1.31B
Net Income - (IS)	663M	802M	1.01B	1.17B	1.31B
Net Income to Common Incl Extra Items	663M	802M	1.01B	1.17B	1.31B
Net Income to Common Excl. Extra Items	663M	802M	1.01B	1.17B	1.31B
Per Share Items
Net EPS - Basic	2.19	2.77	3.57	4.18	4.75
Basic EPS - Continuing Operations	2.19	2.77	3.57	4.18	4.75
Basic Weighted Average Shares Outstanding	303M	289M	283M	280M	276M
Net EPS - Diluted	2.18	2.76	3.56	4.16	4.73
Diluted EPS - Continuing Operations	2.18	2.76	3.56	4.16	4.73
Diluted Weighted Average Shares Outstanding	304M	291M	284M	281M	277M
Normalized Basic EPS	1.92	2.33	2.98	3.46	3.98
Normalized Diluted EPS	1.91	2.31	2.97	3.44	3.96
Dividend Per Share	0.2	0.22	0.28	0.37	0.42
Payout Ratio	9.12	7.85	7.53	8.32	8.64
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.07B	1.24B	1.52B	1.7B	1.85B
EBITA	987M	1.15B	1.42B	1.58B	1.75B
EBIT	987M	1.15B	1.42B	1.58B	1.75B
EBITDAR	1.22B	1.39B	1.69B	1.88B	2.07B
Effective Tax Rate - (Ratio)	25.77	25.48	25.2	24.46	25.78
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	211M	282M	351M	389M	464M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	19.53M	-7.49M	-10.24M	-10.62M	-8.83M
Normalized Net Income	581M	674M	844M	967M	1.1B
Interest on Long-Term Debt	48.61M	111M	157M	177M	194M
Supplemental Operating Expense Items
Net Rental Expense, Total	147M	153M	169M	188M	224M
Imputed Operating Lease Interest Expense	30.26M	35.99M	54.5M	62.19M	72.25M
Imputed Operating Lease Depreciation	116M	117M	115M	125M	151M
Stock-Based Comp., Other (Total)	8.62M	14.19M	13.1M	15.51M	16.02M
Total Stock-Based Compensation	8.62M	14.19M	13.1M	15.51M	16.02M

Fiscal Period: February	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	71.06M	101M	314M	123M	332M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	-	1.98M	12.36M	8.92M
Total Cash And Short Term Investments	71.06M	101M	316M	135M	340M
Accounts Receivable, Total	26.26M	56.29M	32.47M	46.64M	38.5M
Other Receivables	-	-	26.91M	54.62M	559K
Total Receivables	26.26M	56.29M	59.38M	101M	39.06M
Inventory	591M	957M	917M	921M	1.1B
Prepaid Expenses	13.14M	23.46M	13.67M	13.91M	38.45M
Other Current Assets, Total	15.99M	18.76M	3.34M	29.97M	815K
Total Current Assets	717M	1.16B	1.31B	1.2B	1.52B
Gross Property Plant And Equipment	2.86B	3.2B	3.54B	4.07B	4.67B
Accumulated Depreciation	-615M	-702M	-798M	-910M	-1.01B
Net Property Plant And Equipment	2.24B	2.5B	2.74B	3.16B	3.66B
Long-term Investments	212M	268M	319M	1.13B	1.29B
Goodwill	728M	728M	728M	728M	802M
Other Intangibles, Total	164M	165M	168M	181M	178M
Deferred Tax Assets Long-Term	-	-	-	-	25.71M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	290K	-	-	85.36M	89.85M
Total Assets	4.06B	4.82B	5.26B	6.48B	7.56B
Liabilities
Accounts Payable, Total	66.65M	103M	109M	117M	127M
Accrued Expenses, Total	163M	196M	179M	193M	285M
Short-term Borrowings	89.39M	-	-	-	-
Current Portion of Long-Term Debt	261M	516M	21.46M	274M	398M
Current Portion of Leases	201M	219M	235M	279M	378M
Current Income Taxes Payable	62.52M	72.57M	64M	81.37M	64.31M
Other Current Liabilities	69.28M	55.77M	69.45M	70.23M	95.67M
Total Current Liabilities	912M	1.16B	678M	1.01B	1.35B
Long-Term Debt	1.54B	1.74B	2.24B	2.01B	2.23B
Long-Term Leases	1.53B	1.74B	1.83B	2.15B	2.39B
Deferred Tax Liability Non Current	152M	145M	127M	123M	103M
Other Non Current Liabilities	-	-	-	-	31.98M
Total Liabilities	4.13B	4.79B	4.88B	5.29B	6.1B
Common Stock, Total	479M	488M	523M	1.28B	1.27B
Additional Paid In Capital	32.92M	42.68M	49.54M	51.72M	57.57M
Retained Earnings	-578M	-514M	-227M	-225M	129M
Treasury Stock	-	-	-	-20M	-29.97M
Comprehensive Income and Other	-325K	11.74M	34.73M	106M	32.68M
Total Common Equity	-66.03M	28.41M	381M	1.19B	1.46B
Total Equity	-66.03M	28.41M	381M	1.19B	1.46B
Total Liabilities And Equity	4.06B	4.82B	5.26B	6.48B	7.56B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	293M	285M	279M	277M	273M
ECS Total Common Shares Outstanding	293M	285M	279M	277M	273M
Book Value / Share	-0.23	0.1	1.37	4.29	5.34
Tangible Book Value	-958M	-864M	-515M	280M	476M
Tangible Book Value Per Share	-3.27	-3.04	-1.85	1.01	1.74
Total Debt	3.62B	4.22B	4.33B	4.71B	5.4B
Net Debt	3.55B	4.12B	4.02B	4.57B	5.06B
Debt Equivalent Oper. Leases	1.17B	1.22B	1.35B	1.5B	1.79B
Equity Method Investments, Total	212M	268M	319M	1.13B	1.29B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	70.34M	70.34M	160M	218M	218M
Buildings, Total	89.65M	89.66M	89.7M	95.36M	95.64M
Machinery, Total	715M	785M	881M	952M	1.08B
Full Time Employees	-	-	-	-	-
Part Time Employees	-	-	-	-	-

Fiscal Period: February	2022	2023	2024	2025	2026
Net Income	663M	802M	1.01B	1.17B	1.31B
Depreciation & Amortization - CF	277M	310M	343M	385M	434M
Depreciation & Amortization, Total	277M	310M	343M	385M	434M
Amortization of Deferred Charges, Total - (CF)	22.78M	22.19M	22.91M	26.07M	26.44M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-10.35M
(Income) Loss On Equity Investments - (CF)	-33.18M	-45.4M	-75.29M	-130M	-192M
Stock-Based Compensation (CF)	8.62M	14.19M	13.1M	15.51M	16.02M
Other Operating Activities, Total	16.91M	118M	165M	186M	233M
Change In Accounts Receivable	-5.7M	-28.77M	24.11M	-12.5M	-255K
Change In Inventories	39.73M	-366M	40.36M	-4.28M	-54.28M
Change In Accounts Payable	30.1M	46.24M	-10.38M	-10.34M	37.86M
Change In Income Taxes	49.54M	7.88M	-11.35M	20.61M	-17.26M
Change in Other Net Operating Assets	-3.59M	-10.33M	9.79M	-242K	-21.93M
Cash from Operations	1.07B	869M	1.53B	1.64B	1.76B
Capital Expenditure	-137M	-134M	-253M	-213M	-249M
Sale of Property, Plant, and Equipment	839K	278K	938K	736K	1.08M
Cash Acquisitions	-	-	-	-	-182M
Sale (Purchase) of Real Estate properties	-	-	-	-	-
Sale (Purchase) of Intangible assets	-22.74M	-22.78M	-26.09M	-34.04M	-24.03M
Investment in Marketable and Equity Securities, Total	-	-	26.96M	22M	56.59M
Other Investing Activities, Total	-	-	-	-	-6.55M
Cash from Investing	-159M	-157M	-251M	-224M	-403M
Short Term Debt Issued, Total	88.38M	-	-	-	-
Long-Term Debt Issued, Total	750M	710M	514M	-	600M
Total Debt Issued	838M	710M	514M	-	600M
Short Term Debt Repaid, Total	-	-88.38M	-	-	-
Long-Term Debt Repaid, Total	-1.01B	-504M	-785M	-318M	-640M
Total Debt Repaid	-1.01B	-592M	-785M	-318M	-640M
Issuance of Common Stock	19.16M	19.24M	39.27M	19.77M	8.84M
Repurchase of Common Stock	-1.06B	-689M	-656M	-1.09B	-864M
Common Dividends Paid	-60.46M	-62.98M	-76.13M	-97.24M	-113M
Common & Preferred Stock Dividends Paid	-60.46M	-62.98M	-76.13M	-97.24M	-113M
Other Financing Activities, Total	-4.17M	-68.03M	-104M	-125M	-140M
Cash from Financing	-1.28B	-682M	-1.07B	-1.61B	-1.15B
Net Change in Cash	-368M	30.2M	213M	-191M	209M
Supplemental Items
Cash Interest Paid	91.81M	116M	167M	192M	214M
Cash Income Tax Paid (Refund)	161M	272M	362M	391M	469M
Levered Free Cash Flow	779M	492M	937M	1.02B	1.16B
Unlevered Free Cash Flow	833M	564M	1.04B	1.13B	1.29B
Change In Net Working Capital	-69.5M	343M	-56.77M	33.07M	5.04M
Net Debt Issued / Repaid	-170M	118M	-271M	-318M	-40.33M

Fiscal Period: February	2022	2023	2024	2025	2026
Profitability
Return on Assets	14.89	16.15	17.61	16.82	15.55
Return on Total Capital	16.79	18.4	19.81	18.62	17.12
Return On Equity %	493.39	-4.26K	493.8	148.94	99.04
Return on Common Equity	493.39	-4.26K	493.8	148.94	99.04
Margin Analysis
Gross Profit Margin %	47.31	46.53	47.43	45.12	45.05
SG&A Margin	17.64	17.25	17.28	14.5	15.07
EBITDA Margin %	24.72	24.55	25.98	26.46	25.51
EBITA Margin %	22.79	22.71	24.21	24.65	24.07
EBIT Margin %	22.79	22.71	24.21	24.65	24.07
Income From Continuing Operations Margin %	15.31	15.87	17.22	18.22	18.05
Net Income Margin %	15.31	15.87	17.22	18.22	18.05
Net Avail. For Common Margin %	15.31	15.87	17.22	18.22	18.05
Normalized Net Income Margin	13.41	13.33	14.39	15.08	15.11
Levered Free Cash Flow Margin	17.98	9.73	15.97	15.87	16.02
Unlevered Free Cash Flow Margin	19.24	11.15	17.8	17.69	17.77
Asset Turnover
Asset Turnover	1.05	1.14	1.16	1.09	1.03
Fixed Assets Turnover	2.02	2.13	2.24	2.18	2.13
Receivables Turnover (Average Receivables)	185.05	122.42	132.2	162.13	170.45
Inventory Turnover (Average Inventory)	3.74	3.49	3.29	3.83	3.94
Short Term Liquidity
Current Ratio	0.79	0.99	1.93	1.18	1.13
Quick Ratio	0.11	0.14	0.55	0.23	0.28
Operating Cash Flow to Current Liabilities	1.17	0.75	2.26	1.62	1.31
Days Sales Outstanding (Average Receivables)	1.97	2.97	2.75	2.29	2.14
Days Outstanding Inventory (Average Inventory)	97.44	104.28	110.57	96.87	92.4
Average Days Payable Outstanding	10.82	10.06	12.69	11.94	10.66
Cash Conversion Cycle (Average Days)	88.58	97.2	100.63	87.22	83.88
Long Term Solvency
Total Debt/Equity	-5.48K	14.85K	1.14K	396.35	370.61
Total Debt / Total Capital	101.86	99.33	91.92	79.85	78.75
LT Debt/Equity	-4.64K	12.26K	1.07K	349.85	317.3
Long-Term Debt / Total Capital	86.35	82.02	86.49	70.49	67.42
Total Liabilities / Total Assets	101.62	99.41	92.76	81.67	80.74
EBIT / Interest Expense	10.82	9.95	8.25	8.43	8.56
EBITDA / Interest Expense	13.86	12.63	10.24	10.49	10.68
(EBITDA - Capex) / Interest Expense	12.36	11.47	8.78	9.35	9.46
Total Debt / EBITDA	2.86	2.89	2.46	2.4	2.48
Net Debt / EBITDA	2.8	2.83	2.28	2.33	2.32
Total Debt / (EBITDA - Capex)	3.21	3.19	2.87	2.69	2.79
Net Debt / (EBITDA - Capex)	3.14	3.11	2.66	2.61	2.62
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.56	16.67	16.12	9.3	13.14
Gross Profit, 1 Yr. Growth %	7.18	14.74	18.37	10.73	12.96
EBITDA, 1 Yr. Growth %	7.13	15.88	23.02	11.33	9.08
EBITA, 1 Yr. Growth %	6.66	16.29	23.94	11.29	10.47
EBIT, 1 Yr. Growth %	6.66	16.29	23.94	11.29	10.47
Earnings From Cont. Operations, 1 Yr. Growth %	17.51	20.91	26.01	15.64	12.06
Net Income, 1 Yr. Growth %	17.51	20.91	26.01	15.64	12.06
Normalized Net Income, 1 Yr. Growth %	9.37	16.02	25.53	14.51	13.38
Diluted EPS Before Extra, 1 Yr. Growth %	20.44	26.61	28.99	16.85	13.7
Accounts Receivable, 1 Yr. Growth %	27.81	114.36	-42.31	43.62	-17.45
Inventory, 1 Yr. Growth %	-6.3	61.98	-4.22	0.47	19.77
Net Property, Plant and Equip., 1 Yr. Growth %	9.15	11.61	9.47	15.2	15.84
Total Assets, 1 Yr. Growth %	-3.79	18.61	9.21	23.16	16.59
Tangible Book Value, 1 Yr. Growth %	72.68	-9.8	-40.42	-154.35	70.09
Common Equity, 1 Yr. Growth %	-119.72	-143.02	1.24K	212	22.52
Cash From Operations, 1 Yr. Growth %	19.95	-25.03	76.17	7.39	7.12
Capital Expenditures, 1 Yr. Growth %	-2.33	-1.99	88.49	-15.77	16.88
Levered Free Cash Flow, 1 Yr. Growth %	20.68	-36.69	93.8	8.27	13.82
Unlevered Free Cash Flow, 1 Yr. Growth %	18.65	-32.37	85.61	8.65	13.32
Dividend Per Share, 1 Yr. Growth %	12.4	9.94	28.03	29.94	15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.93	12.02	16.4	12.66	11.2
Gross Profit, 2 Yr. CAGR %	7.13	10.9	16.54	10.95	11.84
EBITDA, 2 Yr. CAGR %	7.91	11.42	19.32	17.03	10.2
EBITA, 2 Yr. CAGR %	7.26	11.37	19.97	17.44	10.88
EBIT, 2 Yr. CAGR %	7.26	11.37	19.97	17.44	10.88
Earnings From Cont. Operations, 2 Yr. CAGR %	8.43	19.2	23.44	20.72	13.84
Net Income, 2 Yr. CAGR %	8.43	19.2	23.44	20.72	13.84
Normalized Net Income, 2 Yr. CAGR %	9.81	12.64	20.59	19.9	13.94
Diluted EPS Before Extra, 2 Yr. CAGR %	10.67	23.49	27.79	22.77	15.27
Accounts Receivable, 2 Yr. CAGR %	-13.34	65.52	11.2	-8.98	8.88
Inventory, 2 Yr. CAGR %	-2.65	23.2	24.56	-1.9	9.69
Net Property, Plant and Equip., 2 Yr. CAGR %	7.85	10.38	10.54	12.3	15.52
Total Assets, 2 Yr. CAGR %	4.57	6.82	13.81	15.98	19.83
Tangible Book Value, 2 Yr. CAGR %	-0.78	24.8	-26.69	-43.1	-3.85
Common Equity, 2 Yr. CAGR %	-15.37	-70.87	140.16	546.73	95.52
Cash From Operations, 2 Yr. CAGR %	20.63	-1.11	14.92	37.55	7.26
Capital Expenditures, 2 Yr. CAGR %	8.84	-2.16	35.92	26	-0.78
Levered Free Cash Flow, 2 Yr. CAGR %	16.14	-12.72	9.84	45.09	11.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	14.33	-10.42	11.94	42.01	11.13
Dividend Per Share, 2 Yr. CAGR %	6.92	11.16	18.64	28.98	22.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.87	10.09	13.37	13.98	12.82
Gross Profit, 3 Yr. CAGR %	6.2	9.61	13.33	12.2	11.61
EBITDA, 3 Yr. CAGR %	5.57	10.5	15.11	16.6	14.32
EBITA, 3 Yr. CAGR %	5.3	10.19	15.36	17	15.07
EBIT, 3 Yr. CAGR %	5.3	10.19	15.36	17	15.07
Earnings From Cont. Operations, 3 Yr. CAGR %	6.76	12.44	21.43	20.78	17.76
Net Income, 3 Yr. CAGR %	6.76	12.44	21.43	20.78	17.76
Normalized Net Income, 3 Yr. CAGR %	7.36	11.84	16.73	18.53	17.68
Diluted EPS Before Extra, 3 Yr. CAGR %	9.51	15.74	25.29	24.04	19.67
Accounts Receivable, 3 Yr. CAGR %	-9.85	17.2	16.48	21.1	-11.89
Inventory, 3 Yr. CAGR %	0.55	15.36	13.28	15.95	4.85
Net Property, Plant and Equip., 3 Yr. CAGR %	7.71	9.09	10.07	12.07	13.47
Total Assets, 3 Yr. CAGR %	6.55	9.05	7.61	16.85	16.18
Tangible Book Value, 3 Yr. CAGR %	-7.08	-3.88	-2.46	-33.65	-18.03
Common Equity, 3 Yr. CAGR %	-40.74	-32.46	4.38	162.05	271.44
Cash From Operations, 3 Yr. CAGR %	15.83	5.86	19.88	12.35	26.55
Capital Expenditures, 3 Yr. CAGR %	-1.16	5.1	21.74	15.88	22.88
Levered Free Cash Flow, 3 Yr. CAGR %	25.89	-5.22	13.23	9.44	33.96
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.07	-4.02	14.14	10.83	31.85
Dividend Per Share, 3 Yr. CAGR %	7.94	7.92	16.52	22.29	24.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.88	9.12	10.58	11.11	12.5
Gross Profit, 5 Yr. CAGR %	7.31	8	10.22	10.14	11.33
EBITDA, 5 Yr. CAGR %	9.07	8.81	10.87	13.04	13.12
EBITA, 5 Yr. CAGR %	8.86	8.72	10.94	13	13.54
EBIT, 5 Yr. CAGR %	8.86	8.72	10.94	13	13.54
Earnings From Cont. Operations, 5 Yr. CAGR %	8.28	9.07	13.14	15.68	18.33
Net Income, 5 Yr. CAGR %	8.28	9.07	13.14	15.68	18.33
Normalized Net Income, 5 Yr. CAGR %	8.69	8.53	12.47	14.96	15.61
Diluted EPS Before Extra, 5 Yr. CAGR %	12.01	12.67	16.48	18.5	21.18
Accounts Receivable, 5 Yr. CAGR %	11.28	29.82	-1.95	5.93	13.38
Inventory, 5 Yr. CAGR %	4.88	14.29	9.54	8.12	11.83
Net Property, Plant and Equip., 5 Yr. CAGR %	38.68	38.5	8.83	10.36	12.22
Total Assets, 5 Yr. CAGR %	16.87	20.03	9.4	11.77	12.34
Tangible Book Value, 5 Yr. CAGR %	4.63	-5.11	-15.49	-22.06	-3.02
Common Equity, 5 Yr. CAGR %	-8.02	-35.39	3.71	66.74	34.17
Cash From Operations, 5 Yr. CAGR %	16.11	6.4	17.42	17.55	14.66
Capital Expenditures, 5 Yr. CAGR %	0.8	8.4	12.27	13.01	12.18
Levered Free Cash Flow, 5 Yr. CAGR %	16.11	0.43	19.14	12	12.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.51	2.26	18.49	12.22	12.92
Dividend Per Share, 5 Yr. CAGR %	8.04	8.08	12.1	15.9	18.78